APOA1 and neoplasm: The identified high-density lipoprotein component APOA1, is an LXR/RXR target known to control cholesterol efflux but which also has immune modulating activities, such as promoting polarization of tumor-associated macrophages towards the anti-tumor M1-like macrophage [26].